Download Files:
286 CAD – 2,768 CADPrice range: 286 CAD through 2,768 CAD
Products Details
Product Description
– Icrucumab ( IMC-18F1) is a humanized IgG1 monoclonal antibody targeting vascular endothelial growth factor receptor-1.Icrucumab has antitumor activity.Icrucumab has been studied in metastatic colon cancer.
Web ID
– T76866
Storage Temperature
– -20℃
Shipping
– Blue Ice
References
– LoRusso PM, et al. Icrucumab, a fully human monoclonal antibody against the vascular endothelial growth factor receptor-1, in the treatment of patients with advanced solid malignancies: a Phase 1 study. Invest New Drugs. 2014 Apr;32(2):303-11.
CAS Number
– 1024603-92-6
Molecular Weight
Compound Purity
– > 95%
Pathway
– Tyrosine Kinase/Adaptors|||Angiogenesis
Product type
– Inhibitory Antibodies
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
Related Products
1000 in stock
1000 in stock
1000 in stock
